Dutasteride, a 5 alpha reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia
The present study showed that despite their ameliorating effect on prostatic hyperplasia, dutasteride contributed significantly to chronic prostatic inflammation.
Authors
- Yusuke Fukiage
- Osamu Yokoyama
- Manami Tsutsumiuchi
- Hisato Kobayashi (ORCID: https://orcid.org/0000-0002-1346-6729)
- So Inamura (ORCID: https://orcid.org/0000-0002-1261-5059)
- Motohiro Kobayashi (ORCID: https://orcid.org/0000-0002-7607-0801)
- Naoki Terada (ORCID: https://orcid.org/0009-0005-1082-6089)
- Masato Fukushima (ORCID: https://orcid.org/0000-0001-9120-9819)
- Minekatsu Taga (ORCID: https://orcid.org/0000-0002-1767-9799)
- Masaya Seki
Institutions
- University of Fukui (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1111/iju.15612
- Citations
- 3
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.61